Hyperfine (HYPR) Competitors $1.39 -0.81 (-36.77%) As of 11:17 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HYPR vs. CBLL, SMLR, TMCI, DCTH, DRTS, NPCE, RXST, CARL, TCMD, and SNWVShould you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include CeriBell (CBLL), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Alpha Tau Medical (DRTS), NeuroPace (NPCE), RxSight (RXST), Carlsmed (CARL), Tactile Systems Technology (TCMD), and Sanuwave Health (SNWV). These companies are all part of the "medical equipment" industry. Hyperfine vs. Its Competitors CeriBell Semler Scientific Treace Medical Concepts Delcath Systems Alpha Tau Medical NeuroPace RxSight Carlsmed Tactile Systems Technology Sanuwave Health Hyperfine (NASDAQ:HYPR) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk. Is HYPR or CBLL more profitable? CeriBell has a net margin of -63.83% compared to Hyperfine's net margin of -364.54%. CeriBell's return on equity of -48.42% beat Hyperfine's return on equity.Company Net Margins Return on Equity Return on Assets Hyperfine-364.54% -84.82% -69.39% CeriBell -63.83%-48.42%-28.50% Which has preferable valuation and earnings, HYPR or CBLL? CeriBell has higher revenue and earnings than Hyperfine. CeriBell is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHyperfine$12.89M8.48-$40.72M-$0.52-2.68CeriBell$65.44M7.16-$40.46M-$2.99-4.27 Does the media refer more to HYPR or CBLL? In the previous week, Hyperfine had 4 more articles in the media than CeriBell. MarketBeat recorded 6 mentions for Hyperfine and 2 mentions for CeriBell. CeriBell's average media sentiment score of 0.89 beat Hyperfine's score of 0.44 indicating that CeriBell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hyperfine 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CeriBell 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer HYPR or CBLL? Hyperfine presently has a consensus price target of $1.28, indicating a potential downside of 7.74%. CeriBell has a consensus price target of $32.14, indicating a potential upside of 151.57%. Given CeriBell's stronger consensus rating and higher possible upside, analysts plainly believe CeriBell is more favorable than Hyperfine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperfine 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25CeriBell 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.78 Do insiders & institutionals believe in HYPR or CBLL? 15.0% of Hyperfine shares are held by institutional investors. 31.0% of Hyperfine shares are held by company insiders. Comparatively, 20.1% of CeriBell shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryCeriBell beats Hyperfine on 9 of the 15 factors compared between the two stocks. Get Hyperfine News Delivered to You Automatically Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HYPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HYPR vs. The Competition Export to ExcelMetricHyperfineMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$111.19M$7.07B$6.16B$10.59BDividend YieldN/A1.18%5.73%4.78%P/E Ratio-2.7226.9085.6727.43Price / Sales8.4828.63584.77183.24Price / CashN/A21.7037.3961.86Price / Book2.085.2312.516.79Net Income-$40.72M$178.09M$3.32B$276.90M7 Day Performance-29.75%-1.46%707.60%0.29%1 Month Performance-1.35%6.62%935.16%7.59%1 Year Performance39.10%4.92%2,403.40%39.41% Hyperfine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HYPRHyperfine1.0445 of 5 stars$1.39-36.8%$1.28-7.7%+124.5%$111.19M$12.89M-2.72190News CoverageGap DownHigh Trading VolumeCBLLCeriBell2.2944 of 5 stars$12.57-0.6%$32.14+155.7%N/A$463.43M$65.44M-4.20N/APositive NewsSMLRSemler Scientific3.2145 of 5 stars$30.75+0.6%$74.25+141.5%-6.8%$452.43M$56.29M12.65120Gap UpTMCITreace Medical Concepts2.3258 of 5 stars$6.30-0.9%$9.83+56.1%+15.0%$401.78M$209.36M-7.97250Analyst ForecastDCTHDelcath Systems2.4515 of 5 stars$10.80-2.7%$24.50+126.9%+26.8%$388.29M$37.21M216.0060Gap UpDRTSAlpha Tau Medical2.0952 of 5 stars$4.22-2.1%$9.00+113.3%+77.5%$365.57MN/A-8.7980NPCENeuroPace3.5793 of 5 stars$10.77-1.4%$16.60+54.1%+70.0%$361.25M$79.91M-12.82170Positive NewsRXSTRxSight2.854 of 5 stars$8.49-3.5%$10.00+17.8%-84.1%$360.06M$139.93M-10.61220CARLCarlsmedN/A$14.48+11.6%N/AN/A$344.76M$27.17M0.00100TCMDTactile Systems Technology3.6036 of 5 stars$15.17-0.2%$16.83+11.0%+1.9%$338.84M$298.85M24.471,037SNWVSanuwave Health2.8852 of 5 stars$40.82+9.1%$55.00+34.7%N/A$320.70M$32.63M-4.9540High Trading Volume Related Companies and Tools Related Companies CeriBell Alternatives Semler Scientific Alternatives Treace Medical Concepts Alternatives Delcath Systems Alternatives Alpha Tau Medical Alternatives NeuroPace Alternatives RxSight Alternatives Carlsmed Alternatives Tactile Systems Technology Alternatives Sanuwave Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HYPR) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredOptions Pro Reveals His #1 Retirement Income TradeThe current market is creating a perfect setup for my favorite trading strategy — one that doesn’t rely on ris...Base Camp Trading | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hyperfine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
